185 related articles for article (PubMed ID: 22161552)
1. Exposure to oral bisphosphonates and risk of cancer.
Cardwell CR; Abnet CC; Veal P; Hughes CM; Cantwell MM; Murray LJ
Int J Cancer; 2012 Sep; 131(5):E717-25. PubMed ID: 22161552
[TBL] [Abstract][Full Text] [Related]
2. Exposure to oral bisphosphonates and risk of esophageal cancer.
Cardwell CR; Abnet CC; Cantwell MM; Murray LJ
JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457
[TBL] [Abstract][Full Text] [Related]
3. Exposure to oral bisphosphonates and risk of gastrointestinal cancer.
Choi D; Choi S; Chang J; Park SM
Osteoporos Int; 2020 Apr; 31(4):775-782. PubMed ID: 32034451
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
Oh YH; Yoon C; Park SM
World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
[TBL] [Abstract][Full Text] [Related]
5. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.
Green J; Czanner G; Reeves G; Watson J; Wise L; Beral V
BMJ; 2010 Sep; 341():c4444. PubMed ID: 20813820
[TBL] [Abstract][Full Text] [Related]
6. Oral bisphosphonate use and lung cancer incidence among postmenopausal women.
Tao MH; Chen S; Freudenheim JL; Cauley JA; Johnson KC; Mai X; Sarto GE; Wakelee H; Boffetta P; Wactawski-Wende J
Ann Oncol; 2018 Jun; 29(6):1476-1485. PubMed ID: 29617712
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
8. Oral bisphosphonate use and the risk of female breast, ovarian, and cervical cancer: a nationwide population-based cohort study.
Bae YS; Chang J; Park SM
Arch Osteoporos; 2019 Mar; 14(1):41. PubMed ID: 30888545
[TBL] [Abstract][Full Text] [Related]
9. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.
Kim SY; Schneeweiss S; Katz JN; Levin R; Solomon DH
J Bone Miner Res; 2011 May; 26(5):993-1001. PubMed ID: 21542002
[TBL] [Abstract][Full Text] [Related]
10. Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.
Passarelli MN; Newcomb PA; LaCroix AZ; Lane DS; Ho GY; Chlebowski RT
J Bone Miner Res; 2013 Sep; 28(9):2043-8. PubMed ID: 23519920
[TBL] [Abstract][Full Text] [Related]
11. Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.
Coloma PM; de Ridder M; Bezemer I; Herings RM; Gini R; Pecchioli S; Scotti L; Rijnbeek P; Mosseveld M; van der Lei J; Trifirò G; Sturkenboom M;
Osteoporos Int; 2016 May; 27(5):1857-67. PubMed ID: 26694594
[TBL] [Abstract][Full Text] [Related]
12. Oral bisphosphonate use and breast cancer incidence in postmenopausal women.
Chlebowski RT; Chen Z; Cauley JA; Anderson G; Rodabough RJ; McTiernan A; Lane DS; Manson JE; Snetselaar L; Yasmeen S; O'Sullivan MJ; Safford M; Hendrix SL; Wallace RB
J Clin Oncol; 2010 Aug; 28(22):3582-90. PubMed ID: 20567009
[TBL] [Abstract][Full Text] [Related]
13. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
[TBL] [Abstract][Full Text] [Related]
14. Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case-control studies using two primary-care databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
Br J Cancer; 2013 Aug; 109(3):795-806. PubMed ID: 23868009
[TBL] [Abstract][Full Text] [Related]
15. Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study.
Garriga C; Pazianas M; Hawley S; Delmestri A; Prieto-Alhambra D; Cooper C; Judge A
Ann N Y Acad Sci; 2018 Mar; 1415(1):34-46. PubMed ID: 29363763
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral bisphosphonates for osteoporosis on development of skeletal metastases in women with breast cancer: results from a pharmaco-epidemiological study.
Kremer R; Gagnon B; Meguerditchian AN; Nadeau L; Mayo N
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25278509
[TBL] [Abstract][Full Text] [Related]
17. Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
Pazianas M; Abrahamsen B; Eiken PA; Eastell R; Russell RG
Osteoporos Int; 2012 Nov; 23(11):2693-701. PubMed ID: 22392160
[TBL] [Abstract][Full Text] [Related]
18. Oral bisphosphonates and the risk of colorectal cancer: a meta-analysis.
Yang G; Hu H; Zeng R; Huang J
J Clin Gastroenterol; 2013 Oct; 47(9):741-8. PubMed ID: 24030705
[TBL] [Abstract][Full Text] [Related]
19. Post-diagnostic oral bisphosphonate use and colorectal cancer mortality: a population-based cohort study within the UK Clinical Practice Research Datalink.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Br J Cancer; 2015 Jun; 113(1):123-6. PubMed ID: 25989268
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
